Literature DB >> 26255861

Clinical analysis of drug-induced sleep endoscopy for the OSA patient.

Dina Golbin1, Brandon Musgrave1, Eric Succar1, Kathleen Yaremchuk1.   

Abstract

OBJECTIVES/HYPOTHESIS: To determine if the use of drug-induced sleep endoscopy (DISE) and transoral robotic surgery (TORS) for the treatment of obstructive sleep apnea (OSA) is associated with improved outcomes and acceptable complication rates when compared to uvulopalatopharyngoplasty (UPPP) with or without tonsillectomy (± T).
METHODS: A retrospective cohort review was performed comparing 40 patients who had previously undergone UPPP ± T with 64 patients who had DISE, UPPP ± T, and possible TORS base-of-tongue resection and/or partial epiglottectomy. Apnea-hypopnea index (AHI), Epworth Sleepiness Scale (ESS), body mass index, sex, hospital length of stay, hospital charges, hospital readmissions, emergency department visits, and major complications were compared for both groups.
RESULTS: The 40 patients who underwent UPPP ± T without DISE showed a significant reduction in AHI of -20.1 (P = 0.001) and a complication rate of 3% (P = 0.001). There was no significant change in ESS (-2.2; P = 0.734). The 64 patients who underwent DISE and subsequent procedures showed a significant reduction in AHI of -21.4 (P = 0.001) and a complication rate of 34.7% (P = 0.001). There was no significant difference in the ESS (+0.1; P = 0.734) or AHI (P = 0.092) between the two groups.
CONCLUSION: Patients who underwent UPPP ± T without DISE did not show a statistically significant difference in outcomes compared to the patients who underwent DISE with other procedures, including TORS. The TORS patients had increased total costs and length of stay that were statistically significant and had increased complications that were not statistically significant.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Obstructive sleep apnea; base of tongue; drug-induced sleep endoscopy (DISE); epiglottis; transoral robotic surgery; uvulopalatopharyngoplasty

Mesh:

Substances:

Year:  2015        PMID: 26255861     DOI: 10.1002/lary.25516

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Test-retest reliability of drug-induced sleep endoscopy using midazolam.

Authors:  Jung-Soo Kim; Sung Jae Heo
Journal:  J Clin Sleep Med       Date:  2020-02-06       Impact factor: 4.062

2.  The aging effect on upper airways collapse of patients with obstructive sleep apnea syndrome.

Authors:  Claudio Vicini; Andrea De Vito; Giannicola Iannella; Riccardo Gobbi; Ruggero Massimo Corso; Filippo Montevecchi; Antonella Polimeni; Marco De Vincentiis; Giuseppe Meccariello; Giovanni D'agostino; Giovanni Cammaroto; Francesco Stomeo; Giuseppe Magliulo
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-13       Impact factor: 2.503

Review 3.  [Drug-induced sedation endoscopy-quo vadis? : Review and outlook].

Authors:  M Herzog; J T Maurer
Journal:  HNO       Date:  2017-02       Impact factor: 1.284

4.  Insights into Friedman stage II and III OSA patients through drug-induced sleep endoscopy.

Authors:  Chen Zhao; Alonço Viana; Yifei Ma; Robson Capasso
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 2.895

5.  High Tongue Position is a Risk Factor for Upper Airway Concentric Collapse in Obstructive Sleep Apnea: Observation Through Sleep Endoscopy.

Authors:  Chen Zhao; Alonço Viana; Yifei Ma; Robson Capasso
Journal:  Nat Sci Sleep       Date:  2020-10-19

Review 6.  Transoral robotic surgery for the management of obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Giuseppe Meccariello; Giovanni Cammaroto; Filippo Montevecchi; Paut T Hoff; Matthew E Spector; Hesham Negm; Medhat Shams; Chiara Bellini; Ermelinda Zeccardo; Claudio Vicini
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-24       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.